Lana Skirboll

Last updated

Lana Skirboll is the former director of the National Institutes of Health Office of Science Policy.

Contents

Biography

Skirboll is an international leader in science policy. [1]

She graduated from New York University in 1970 with a bachelor's degree in Biology and completed a master's degree in Physiology in 1972 at Miami University (Ohio). She received her Ph.D. with honors from the Department of Pharmacology, Georgetown University School of Medicine in 1977, and conducted her postdoctoral training in the Departments of Psychiatry and Pharmacology at the Yale School of Medicine. Following her postdoctoral training, she was a Fogarty Fellow at the Karolinska Institute in Stockholm, Sweden in the laboratory of Tomas Hökfelt. Dr. Skirboll is the author of more than 75 scientific publications. After leaving Stockholm, Dr. Skirboll was chief of the Electrophysiology Unit in the Intramural Research Program of the U.S. National Institute of Mental Health (NIMH) prior to joining the U.S. Alcohol Drug Abuse and Mental Health Administration (ADAMHA), as the Deputy Science Advisor. She was subsequently appointed as the Chief of Staff to the Agency Administrator and Associate Administrator for Science, where she focused on animals in research and patent policy. In 1992, when ADAMHA was reorganized and its three research Institutes (NIMH, NIDA, and NIAAA) returned to the NIH, Dr. Skirboll was appointed Director of the Office of Science Policy in the NIMH.

In 1995, Harold Varmus, Director of the U.S. National Institutes of Health (NIH) appointed Dr. Skirboll as Director of the NIH Office of Science Policy. During her tenure, she managed a wide range of policy issues, including the ethical, legal, social, and economic implications of biomedical research; human subject protections; the privacy and confidentiality of research records; [2] conflicts of interest; genetics, health, and society; and dual use research, among others. Her office was responsible for NIH's oversight of gene therapy research, including the activities of the Recombinant DNA Advisory Committee (RAC) [3] [4] as well as for the activities of the HHS Secretary's Advisory Committee on Genetics, Health and Society; the Secretary's Advisory Committee on Xenotransplantation; the National Science Advisory Board for Biosecurity (NSABB); the Clinical Research Policy Analysis and Coordination Program (CRpac); and the NIH Office of Science Education. Dr. Skirboll was the NIH liaison to the U.S. Food and Drug Administration, the Foundation for the NIH, and the HHS Office for Human Research Protections. Her work involved collaboration within the U.S. Government, industry, and foreign governments and institutions.

Under three Presidential Administrations, Dr. Skirboll was the agency’s lead on policy issues related to fetal tissue, cloning, and stem cell research. [5] She was responsible for drafting both the 2000 and 2009 NIH Guidelines for Research Using Human Embryonic Stem Cells. [6] [7] [8]

Starting 2003, Dr. Skirboll worked with NIH Director Elias Zerhouni in creating the NIH Roadmap for Medical Research, the Trans-NIH Nanotechnology Task Force and the NIH program on Public-Private Partnerships. In 2009, Zerhouni named Skirboll to serve as Acting NIH Deputy Director for, and Director of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), the NIH entity responsible for the NIH Common Fund. In this capacity, Dr. Skirboll directed national efforts to identify and address emerging scientific opportunities and rising public health challenges through biomedical research. In addition, Dr. Skirboll directed efforts to develop NIH’s portfolio analysis capabilities and was chair of the NIH Council of Councils. In addition, Dr. Skirboll oversaw NIH’s office of evaluation and the program offices responsible for coordination of research and activities related to research on AIDS, behavioral and social sciences, women's health, disease prevention, rare diseases, and dietary supplements—efforts that reside in DPCPSI as a result of implementing requirements of the NIH Reform Act of 2006. Dr. Skirboll has received three DHHS Secretarial Awards for Distinguished Service and a Presidential Rank Award of Meritorious Executive.

In May 2010, Skirboll joined former NIH Director Elias Zerhouni in a new global science and health consulting firm, the Zerhouni Group, LLC. She recently retired from Vice President and Head of Science Policy at the pharmaceutical company Sanofi after 10 years of service.

Personal life

Skirboll resides in Alexandria, VA and is married to architect and hospital administrator, Leonard Taylor, Jr., who was Senior Vice President for Asset Management at the University of Maryland Medical Systems . She has two grown children, Patrick and Eleanor, and four grandchildren.

Related Research Articles

<span class="mw-page-title-main">National Institutes of Health</span> US government medical research agency

The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.

The Substance Abuse and Mental Health Services Administration is a branch of the U.S. Department of Health and Human Services. SAMHSA is charged with improving the quality and availability of treatment and rehabilitative services in order to reduce illness, death, disability, and the cost to society resulting from substance abuse and mental illnesses. The Administrator of SAMHSA reports directly to the Secretary of the U.S. Department of Health and Human Services. SAMHSA's headquarters building is located outside of Rockville, Maryland.

<span class="mw-page-title-main">Health Insurance Portability and Accountability Act</span> United States federal law concerning health information

The Health Insurance Portability and Accountability Act of 1996 is a United States Act of Congress enacted by the 104th United States Congress and signed into law by President Bill Clinton on August 21, 1996. It modernized the flow of healthcare information, stipulates how personally identifiable information maintained by the healthcare and healthcare insurance industries should be protected from fraud and theft, and addressed some limitations on healthcare insurance coverage. It generally prohibits healthcare providers and healthcare businesses, called covered entities, from disclosing protected information to anyone other than a patient and the patient's authorized representatives without their consent. With limited exceptions, it does not restrict patients from receiving information about themselves. It does not prohibit patients from voluntarily sharing their health information however they choose, nor does it require confidentiality where a patient discloses medical information to family members, friends, or other individuals not a part of a covered entity.

The National Institute of Mental Health (NIMH) is one of 27 institutes and centers that make up the National Institutes of Health (NIH). The NIH, in turn, is an agency of the United States Department of Health and Human Services and is the primary agency of the United States government responsible for biomedical and health-related research.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is one of the National Institutes of Health (NIH) in the United States Department of Health and Human Services. It supports and conducts research aimed at improving the health of children, adults, families, and communities, including:

The Dickey–Wicker Amendment is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the United States Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed. HHS funding includes the funding for the National Institutes of Health (NIH). It is named after Jay Dickey and Roger Wicker, two Republican Representatives. Technically, the Dickey Amendment is a rider to other legislation, which amends the original legislation. The rider receives its name from the name of the Congressman that originally introduced the amendment, Representative Dickey. The Dickey amendment language has been added to each of the Labor, HHS, and Education appropriations acts for fiscal years 1997 through 2009. The original rider can be found in Section 128 of P.L. 104–99.

<span class="mw-page-title-main">National Institute on Drug Abuse</span> Branch of the National Institutes of Health in the United States

The National Institute on Drug Abuse (NIDA) is a United States federal government research institute whose mission is to "advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health."

<span class="mw-page-title-main">Elias Zerhouni</span>

Elias Zerhouni is an Algerian-born American scientist, radiologist and biomedical engineer.

<span class="mw-page-title-main">Elizabeth Nabel</span> American academic

Elizabeth Nabel is an American cardiologist and Executive Vice President of Strategy at ModeX Therapeutics and OPKO Health. Prior to this role, she served as President of Brigham Health and its Brigham and Women's Hospital, Professor of Medicine at Harvard Medical School, and Director of the NIH's National Heart, Lung, and Blood Institute.

Paul Billings is an American doctor, lecturer, researcher, professor, and consultant on genetic information. His major research interests include the impact of genomic information and biotechnology on society, the integration of genomics and diagnostics in to health and medical care and individualized genomic medicine. Dr. Paul Billings is the author of more than 250 publications and books on genomic medicine, has spoken at numerous medical conferences, and appeared on talk shows such as The Oprah Show and 60 Minutes. He is currently the chief medical officer of Natera, chairman of Biological Dynamics, Inc. and Plumcare LLC, and CEO of Synergenz Bioscience, Inc.

<span class="mw-page-title-main">John E. Niederhuber</span>

John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.

The National Institutes of Health Common Fund is an initiative of the National Institutes of Health (NIH) aimed at supporting research collaboration between two or more NIH institutes and centers (ICs). The fund offers flexible support for cutting edge, multidisciplinary, multi-investigator and higher risk research. It is intended to streamline US biomedical research and make it more flexible in response to society's health needs. The high-impact programs it supports are known collectively as the "NIH Roadmap for Medical Research". It is coordinated by the Office of Strategic Coordination, one of the six offices of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) within the Office of the Director.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is part of the United States National Institutes of Health, which in turn is part of the Department of Health and Human Services. NIDDK is approximately the fifth-largest of the 27 NIH institutes. The institute's mission is to support research, training, and communication with the public in the topic areas of "diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases". As of 2021, the Director of the institute is Griffin P. Rodgers, who assumed the position on an acting basis in 2006 and on a permanent basis in 2007.

The Office of the Assistant Secretary for Planning and Evaluation (ASPE) is the principal advisory group to the United States Secretary of the Department of Health and Human Services (HHS) on policy development and provides coordination and support for HHS's strategic and policy planning, planning and development of legislation, program evaluation, data gathering, policy-related research, and regulatory program.

<span class="mw-page-title-main">Mary Jane Rotheram-Borus</span> American licensed psychologist

Mary Jane Rotheram-Borus is a licensed clinical psychologist and professor with the University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences. Rotheram is the professor-in-residence in the Semel Institute for Neuroscience and Human Behavior. She is the Director of the Global Center for Children and Families at UCLA and the former director of the Center for HIV Identification, Prevention, and Treatment Services.

<span class="mw-page-title-main">Susan Blumenthal</span>

Susan Jane Blumenthal is an American physician, global health expert, psychiatrist and public health advocate. With more than two decades of service as a senior government health leader in the administrations of four U.S. presidents, Blumenthal served as the first Deputy Assistant Secretary for Women's Health and director of the Office on Women's Health within the U.S. Department of Health and Human Services (HHS), as well as Assistant Surgeon General of the United States and senior global health advisor within the HHS. She also was a research branch chief at the National Institutes of Health (NIH), and the chair of the NIH Health and Behavior Coordinating Committee. As of 2016, she has served as the senior medical and policy advisor at amfAR, The Foundation for AIDS Research, a senior fellow in health policy at New America, and a clinical professor at Tufts and Georgetown Schools of Medicine. Blumenthal is the Public Health Editor of the Huffington Post. She is married to United States Senator Ed Markey.

The Interagency Autism Coordinating Committee (IACC) is a United States federal advisory panel within the Department of Health and Human Services (HHS). It coordinates all efforts within HHS concerning autism spectrum disorder (ASD).

<span class="mw-page-title-main">Della Hann</span> American psychologist and research administrator

Della Marie Hann is an American psychologist and research administrator serving as the associate director for extramural research at the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

<span class="mw-page-title-main">Kathy Hudson</span> American microbiologist

Kathy Lynn Hudson is an American microbiologist specializing in science policy. She was the deputy director for science, outreach, and policy at the National Institutes of Health from October 2010 to January 2017. Hudson assisted in the creation and launch of All of Us, the BRAIN initiative, and the National Center for Advancing Translational Sciences. She founded the Genetics and Public Policy Center at Johns Hopkins University in 2002. Hudson is an advocate for women in science.

References

  1. ↑ "Lana Skirboll | The Scientist Magazine®". The Scientist. Retrieved 2016-08-06.
  2. ↑ Rule, Committee on Health Research and the Privacy of Health Information: The HIPAA Privacy; Policy, Board on Health Sciences; Services, Board on Health Care; Medicine, Institute of (2009). Front Matter | Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research | The National Academies Press. doi:10.17226/12458. ISBN   978-0-309-12499-7. PMID   20662116.{{cite book}}: |first1= has generic name (help)
  3. ↑ Jenks, Susan (2000-01-19). "Gene Therapy Death — "Everyone Has to Share in the Guilt"". Journal of the National Cancer Institute. 92 (2): 98–100. doi:10.1093/jnci/92.2.98. ISSN   0027-8874. PMID   10639505.
  4. ↑ NIH to Kill DNA Advisory Committee; Director Says Replacement Panel Would Defer to FDA on Gene Proposals, Washington Post, July 12, 1996
  5. ↑ Wade, Nicholas (2001-08-18). "Bush's Stem Cell Policy May Streamline Research". The New York Times. ISSN   0362-4331 . Retrieved 2016-08-06.
  6. ↑ Wadman, Meredith (2010-02-22). "NIH may allow stem-cell lines from younger embryos". Nature News. doi: 10.1038/news.2010.85 .
  7. ↑ Holden, Constance (2010-02-19). "NIH Expands Definition of Human Embryonic Stem Cell". Science - AAAS. Retrieved 2017-12-05.
  8. ↑ "U.S. tweaks stem cell policy". Reuters. 2010-02-19. Retrieved 2016-08-06.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.